首页> 外文期刊>International immunopharmacology >Anti-tumor and immunomodulatory activity of iron hepta-tungsten phosphate oxygen clusters complex
【24h】

Anti-tumor and immunomodulatory activity of iron hepta-tungsten phosphate oxygen clusters complex

机译:铁庚酮磷酸铁氧簇复合物的抗肿瘤和免疫调节活性

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Polyoxometalates (POMs) have attracted a considerable attention due to their unique structural characteristics, physicochemical properties and biological activities. In this study, iron hepta-tungsten phosphate oxygen clusters complex Na12H[Fe(HPW7O28)(2)]center dot 44H(2)O (IHTPO) was synthesized and evaluated for in vitro cytotoxic activities on human hepatoma HepG2, leukemia K562, lung carcinoma A549, and large cell lung cancer NCI-H460 cells, therapeutic efficacies on mice transplantable tumor, and immunomodulatory potentials on the immune response in tumor-bearing mice. IHTPO exhibited lower in vitro cytotoxic activities against four human tumor cell lines, with the IC50 values being higher than 62.5 mu M (ca. 300 mu g/ml). IHTPO, however, significantly inhibited the growth of S180 sarcoma transplanted in mice. It was further showed that IHTPO could not only significantly promote splenocytes proliferation, NK cell and CTL activity from splenocytes, but remarkably enhance serum antigen-specific IgG, IgG2a and IgG2b antibody levels in S180-bearing mice. IHTPO also significantly promoted Th1 cytokines IFN-gamma and IL-2 production, and up-regulated the mRNA expression levels of IFN-gamma, IL-2 and Th1 transcription factors T-bet and STAT-4 in splenocytes from the S180-bearing mice. These results suggested that IHTPO significantly inhibited the growth of mice transplantable tumor, and that its in vivo antitumor activity might be achieved by improving Th1 protective cell-mediated immunity. IHTPO could act as antitumor agent with immunomodulatory activity. (C) 2015 Published by Elsevier B.V.
机译:由于其独特的结构特征,物理化学性质和生物活性,聚血杂项(POMS)引起了相当大的关注。在该研究中,铁庚酮磷酸铁氧簇复合Na 12H [Fe(HPW7O28)(2)]中央点44h(2)o(IHTPO)被合成和评价人肝癌Hepg2,白血病K562,Lung的体外细胞毒性活性癌A549和大型细胞肺癌NCI-H460细胞,对小鼠移植肿瘤的治疗效果,以及对肿瘤小鼠免疫应答的免疫调节潜力。 IHTPO对四种人肿瘤细胞系呈现出较低的体外细胞毒性活动,IC 50值高于62.5μm(约300μg/ ml)。然而,IHTPO显着抑制了在小鼠中移植的S180 SARCOMA的生长。进一步表明,IHTPO不仅可以显着促进脾细胞的脾细胞增殖,NK细胞和CTL活性,而是显着增强S180轴承小鼠中的血清抗原特异性IgG,IgG2A和IgG2B抗体水平。 IHTPO还显着促进了Th1细胞因子IFN-Gamma和IL-2的生产,上调IFN-Gamma,IL-2和TH1转录因子T-BET和STAT-4的MRNA表达水平来自S180轴承小鼠的脾细胞。这些结果表明IHTPO显着抑制了小鼠可移植肿瘤的生长,并且其在体内抗肿瘤活性可以通过改善TH1保护细胞介导的免疫来实现。 IHTPO可以作为具有免疫调节活动的抗肿瘤剂。 (c)2015年由elestvier b.v出版。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号